Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Permanently Discontinued

NEOSTIGMINE OMEGA

OMEGA LABORATORIES LIMITED

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is NEOSTIGMINE OMEGA discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that NEOSTIGMINE OMEGA 0.5MG has been permanently discontinued (last updated February 21, 2023). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is NEOSTIGMINE OMEGA not available?

The reason the manufacturer reported: Business reasons.

Can I still get this?Possibly — same-ingredient product records found
StatusPermanently Discontinued
Same-ingredient products on file6 products
Affected strength0.5MG
Last updated2023-02-21

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

NEOSTIGMINE METHYLSULFATE INJECTION USP

SANDOZ CANADA INCORPORATED

1MG · DIN 00885282

Different strengthSame dosage formSame routeNo current shortage

PROSTIGMIN INJ 1:2000 USP

ICN CANADA LTD.

.5MG · DIN 00869910

Different strengthSame dosage formSame routeNo current shortage

PROSTIGMIN INJ 1:1000 USP

ICN CANADA LTD.

1MG · DIN 00869929

Different strengthSame dosage formSame routeNo current shortage

NEOSTIGMINE METHYLSULFATE INJ 1MG/ML USP

DAVID BULL LABORATORIES (PTY) LTD.

1MG · DIN 01914588

Different strengthSame dosage formSame routeNo current shortage

NEOSTIGMINE METHYLSULFATE INJ 0.5MG/ML USP

DAVID BULL LABORATORIES (PTY) LTD.

.5MG · DIN 01904183

Different strengthSame dosage formSame routeNo current shortage

PROSTIGMIN INJ 1:400 USP

ICN CANADA LTD.

2.5MG · DIN 00869937

Different strengthDifferent dosage formSame routeNo current shortage

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02230593

Strength

0.5MG

Dosage Form

LIQUID

Route

SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR

Active Ingredient

NEOSTIGMINE METHYLSULFATE

See all NEOSTIGMINE METHYLSULFATE products →

Shortage History